Notably, SF3B1-mutant MDS exhibited a clear trend toward higher S100A9 gene expression and protein levels, despite an overall lower inflammatory state in MDS patients [ 190 ].
← all excerpts
Bone marrow microenvironment in myelodysplastic neoplasms: insights into pathogenesis, biomarkers, and therapeutic targets.
1
—
—